Skip to main content
SpringerLink
Log in

Rheumatological Diseases of the Nose and Paranasal Sinuses

  • Chapter
  • First Online:
All Around the Nose

  • 139 Accesses

Abstract

Rheumatological problems occurring in the ear, nose and throat can be difficult both for specialists in rheumatology and in ENT to diagnose. In the main, Churg-Strauss syndrome, polychondropathia, Wegener’s syndrome, aspirin-exacerbated respiratory disease (Samter’s syndrome) and midline granulomata will be mentioned, but reference will also be made to some other conditions. Churg-Strauss syndrome (CSS) is a type of vasculitis of unknown cause leading to necrosis and affecting the smallest diameter vasculature and one which usually presents with bronchioasthma, hypereosinophilia and granulomata located extravascularly. Wegener’s syndrome (WS), which is now known as granulomatosis with polyangiitis (GPA), often presents through ENT symptoms, in fact, in greater than 70% of cases, the nose, sinuses, ear, or trachea are involved. WS classically exhibits a trio of findings: (1) both upper and lower respiratory systems show granulomata with associated necrosis; (2) systemically, lower calibre vessels both arterial and venous are vasculitic; and (3) inflamed renal glomeruli in focal areas. Relapsing polychondritis (RP) affects cartilage, particularly the otic, nasal and laryngo tracheobronchial cartilage, but occasionally can also affect ocular, cardiovascular, dermal and central nervous systems as well as peripheral joints and middle or inner ear. Its course is intermittent, but progressive and is severe in intensity. Aspirin-exacerbated respiratory disease (AERD) (Samter’s triad) involves patients who have asthma, respiratory problems exacerbated by aspirin and nasal polyp formation. It is also called the aspirin triad, AERD or Widal triad. This chapter considers rheumatological disorders affecting the nose and paranasal sinuses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol. 2004;22(4):485–94.

    CAS  PubMed  Google Scholar 

  2. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512–23.

    Article  CAS  PubMed  Google Scholar 

  3. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol. 1951;27:277–301.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine. 1984;63:65–81.

    Article  CAS  PubMed  Google Scholar 

  5. Bacciu A, Bacciu S, Mercante G, Ingegnoli F, Grasselli C, Vaglio A, Pasanisi E, Vincenti V, Garini G, Ronda N, Ferri T, Corradi D, Buzio C. Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol. 2006;126(5):503–9.

    Article  PubMed  Google Scholar 

  6. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–100.

    Article  CAS  PubMed  Google Scholar 

  7. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.

    Article  CAS  PubMed  Google Scholar 

  8. Abril A, Clamia KT, Cohen MD. The Churg-Strauss syndrome (allergic granulomatous angiitis): review update. Semin Arthritis Rheum. 2003;33:106–14.

    Article  PubMed  Google Scholar 

  9. Martin RM, Wilton LV, Mann RD. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf. 1999;8:179–89.

    Article  CAS  PubMed  Google Scholar 

  10. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414–9.

    Article  CAS  PubMed  Google Scholar 

  11. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78:26–37.

    Article  CAS  Google Scholar 

  12. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome. Clinical study and long term follow up of 96 patients. Medicine (Baltimore). 1999;78:26.

    Article  CAS  Google Scholar 

  13. Hoffman GS. Vasculitides. In: Klippel J (Ed.): Primer on the rheumatic diseases.12, 2002; 392–396Atlanta, Arthritis Foundation.

    Google Scholar 

  14. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol. 1988;27:258–64.

    Article  CAS  PubMed  Google Scholar 

  15. Lie JT. Illustrated histopathological classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074–87.

    Article  CAS  PubMed  Google Scholar 

  16. Chumbley LC, Harrison EG, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss Syndrome): report and analysis of 30 cases. Mayo Clin Proc. 1977;52:477–84.

    CAS  PubMed  Google Scholar 

  17. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003;361:587–94.

    Article  PubMed  Google Scholar 

  18. Olsen KD, Neel HB, DeRemee RA, Weiland LH. Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Otolaryngol Head Neck Surg. 1980;88:85–9.

    Article  CAS  PubMed  Google Scholar 

  19. Tanna N. Otolaryngologic manifestations of Wegener granulomatosis. In Meyers AD (editor). Medscape. http://emedicine.medscape.com/article/858001-overview#a1. Accessed 02 July 2015.

  20. Granulomatosis with Polyangiitis (Wegener’s). American College of Rheumatology. https://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Granulomatosis_with_Polyangiitis_%28Wegener_s%29/. Accessed 02 July 2015.

  21. Klippel JH. Primer on the rheumatic diseases, vol. 643. 12th ed. Atlanta, GA: Arthritis Foundation; 2001. p. 392–4.

    Google Scholar 

  22. Gubbels SP, Barkhuizen A, Hwang PH. Head and neck manifestations of Wegener’s granulomatosis. Otolaryngol Clin N Am. 2003;36(4):685–705.

    Article  Google Scholar 

  23. Finley JC, Bloom DC, Thiringer JK. Wegener granulomatosis presenting as an infiltrative retropharyngeal mass with syncope and hypoglossal paresis. Arch Otolaryngol Head Neck Surg. 2004;130(3):361–5.

    Article  PubMed  Google Scholar 

  24. Gota CE. Granulomatosis with Polyangiitis (GPA) (Wegener Granulomatosis). Merck Manual Professional Edition. http://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/granulomatosis-with-polyangiitis-gpa. Accessed 02 July 2015.

  25. Rausmussen N. Management of the ear, nose and throat manifestations of Wegener’s granulomatosis: an otorhinolaryngologist’s perspective. Curr Opin Rheumatol. 2001;13:3–11.

    Article  Google Scholar 

  26. Proft F, Steinbach S, Dechant C, et al. Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener’s). Scand J Rheumatol. 2014;43(6):512–8.

    Article  CAS  PubMed  Google Scholar 

  27. Yang C, Talbot JM, Hwang PH. Bony abnormalities of the paranasal sinuses in patients with Wegener’s granulomatosis. Am J Rhinol. 2001;15:121–5.

    Article  CAS  PubMed  Google Scholar 

  28. Muhle C, Reinhold-Keller E, Richter C, Duncker G, Beigel A, Brinkmann G, Gross WL, Heller M. MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener’s granulomatosis. Eur Radiol. 1997;7(4):566–70.

    Article  CAS  PubMed  Google Scholar 

  29. Provenzale JM, Allen NB. Wegener granulomatosis: CT and MR findings. AJNR Am J Neuroradiol. 1996;17(4):785–92.

    CAS  PubMed  Google Scholar 

  30. Boukes RJ, de Vries-Knoppert WA. Lacrimal gland enlargement as one of the ocular manifestations of Wegener’s granulomatosis. Doc Ophthalmol. 1985;59(1):21–6.

    Article  CAS  PubMed  Google Scholar 

  31. Hoffman GS. Vasculitides. Wegener granulomatosis and Churg-Strauss vasculitis. In: Klippel J, editor. Primer on the rheumatic diseases. 12th ed; 2002. p. 392–6.

    Google Scholar 

  32. Schönermarck U, Csernok E, Trabandt A, Hansen H, Gross WL. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol. 2000;18(4):457–63.

    PubMed  Google Scholar 

  33. Sanders JS, Stegeman CA, Kallenberg CG. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press Res. 2003;26(4):215–20.

    Article  CAS  PubMed  Google Scholar 

  34. White ES, Lynch JP. Pharmacological Therapy for Wegener’s granulomatosis. Drugs. 2006;66(9):12098(20).

    Article  Google Scholar 

  35. Lally L, Lebovics RS, Huang WT, et al. Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res. 2014;66(9):1403–9.

    Article  CAS  Google Scholar 

  36. Hong G, Kim H. Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement. Clin Rheumatol. 2013;32(9):1329–35.

    Article  PubMed  Google Scholar 

  37. Jaksch-Wartenhorst R. Polychondropathia. Wien Arch F Inn Med. 1923;6:93–100.

    Google Scholar 

  38. Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med. 1960;263:51–8.

    Article  CAS  PubMed  Google Scholar 

  39. Childs LF, Rickert S, Wengerman OC, Lebovics R, Blitzer A. Laryngeal manifestations of relapsing polychondritis and a novel treatment option. J Voice. 2012;26(5):587–9.

    Article  PubMed  Google Scholar 

  40. Arnaud L, Mathian A, Haroche J, Gorochov G, Amoura Z. Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev. 2014;13(2):90–5.

    Article  CAS  PubMed  Google Scholar 

  41. Foidart JM, Abe S, Martin GR, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978;299(22):1203–7.

    Article  CAS  PubMed  Google Scholar 

  42. Hansson AS, Heinegard D, Piette JC, Burkhardt H, Holmdahl R. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum. 2001;44(10):2402–12.

    Article  CAS  PubMed  Google Scholar 

  43. Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum. 2002;31(6):384–95.

    Article  PubMed  Google Scholar 

  44. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med. 1998;129(2):114–22.

    Article  CAS  PubMed  Google Scholar 

  45. Kent PD, Michet CJ Jr, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. 2004;16(1):56–61.

    Article  PubMed  Google Scholar 

  46. Serratrice J, Ené N, Granel B, Disdier P, deRoux-Serratrice C, Swiader L, Moulin G, Giovanni A, Weiller PJ. Severe relapsing polychondritis occurring after ear piercing. J Rheumatol. 2003;30(12):2716–7.

    PubMed  Google Scholar 

  47. Kraus VB, Stabler T, Le ET, Saltarelli M, Allen NB. Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis. Arthritis Rheum. 2003;48(10):2942–8.

    Article  CAS  PubMed  Google Scholar 

  48. McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55(3):193–215.

    Article  CAS  Google Scholar 

  49. Lee KS, Ernst A, Trentham DE, Lunn W, Feller-Kopman DJ, Boiselle PM. Relapsing polychondritis: prevalence of expiratory CT airway abnormalities. Radiology. 2006;240(2):565–73.

    Google Scholar 

  50. Yamashita H, Takahashi H, Kubota K, Ueda Y, Ozaki T, Yorifuji H, et al. Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review. Rheumatology (Oxford). 2014;53(8):1482–90.

    Article  Google Scholar 

  51. Mathison DA, Stevenson DD. Aspirin sensitivity in rhinosinusitis and asthma. Immunol Allergy Proc. 1983;5:17–26.

    Google Scholar 

  52. Lumry WR, Curd JG, Stevenson DD. Aspirin-sensitive asthma and rhinosinusitis: current concepts and recent advances. Ear Nose Throat J. 1984;63(2):66–68-70,72-74.

    CAS  PubMed  Google Scholar 

  53. McGeehan M, Bush RK. The mechanisms of aspirin-intolerant asthma and its management. Curr Allergy Asthma Rep. 2002;2(2):117–25.

    Article  PubMed  Google Scholar 

  54. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Invest. 1998;101(4):834–46.

    Article  CAS  Google Scholar 

  55. Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP. Lethal midline granuloma-nasal natural killer/T-cell lymphoma. Am J Clin Oncol. 2006;29(2):202–6.

    Article  PubMed  Google Scholar 

  56. Naleriom RM. Allergic rhinitis. N Engl J Med. 1991;325:860.

    Article  Google Scholar 

  57. Milton CM. Sarcoidosis in ENT practice. Clin Otolaryngol. 1985;10:351–5.

    Article  CAS  PubMed  Google Scholar 

  58. Buyon JP. Systemic lupus erythematosus. Clinical and laboratory features. In: Klippel J, editor. Primer on the rheumatic diseases. 12th ed; 2002. p. 335–46.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, University of Health Sciences, Okmeydanı Training and Research Hospital, İstanbul, Turkey

    Deniz Hancı & Yavuz Uyar

  2. Department of ENT, Stavanger University Hospital, Stavanger, Norway

    Ahmed El-Saggan

Authors
  1. Deniz Hancı
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yavuz Uyar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed El-Saggan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Eskişehir Osmangazi University, Medical Faculty, Department of Otorhinolaryngology, Eskisehir, Turkey

    Cemal Cingi

  2. Department of Otorhinolaryngology, Medical Faculty, Kirikkale University, Kirikkale, Turkey

    Nuray Bayar Muluk

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hancı, D., Uyar, Y., El-Saggan, A. (2020). Rheumatological Diseases of the Nose and Paranasal Sinuses. In: Cingi, C., Bayar Muluk, N. (eds) All Around the Nose. Springer, Cham. https://doi.org/10.1007/978-3-030-21217-9_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21217-9_49

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21216-2

  • Online ISBN: 978-3-030-21217-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation